We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Revvity Logo

Revvity

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.

Latest Revvity Content

3D Cell stock photo
How To Guide

Harness the Power of 3D Cell Model Imaging

This guide explores how researchers can make the most of the latest 3D imaging tools to generate high-quality, relevant results from their cell culture experiments.
Oncology
How To Guide

A Guide to Cell Signaling in Cancer Development and Progression

This guide highlights some of the key pathways that are commonly dysregulated in cancer. It also explores how dysregulation can lead to pathogenesis with examples across a broad range of cell and tissue types.
A close up of someone typing on a laptop.
Product News

Revvity Signals Software and Scitara Expand Strategic Relationship To Accelerate Laboratory Digital Transformation

Revvity announced that its Revvity Signals Software business has entered into a strategic relationship with Scitara – a leading global provider of cloud-based solutions for the scientific industry.
The fontus workstation.
Product News

Revvity Accelerates NGS Library Prep With Introduction of New Fontus Automated Liquid Handling Workstation at 2023 AACC

Revvity announced the launch of the Fontus™ Automated Liquid Handling Workstation, designed to deliver easier and faster workflows which enable better results for next generation sequencing (NGS) and diagnostic research applications.
A picture of medicines.
Industry Insight

Failing Faster To Succeed Sooner in Drug Discovery

Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.
HIVE products in boxes.
Product News

Honeycomb Biotechnologies and Revvity Launch New Solutions To Expand the Frontiers of Single Cell Research

Honeycomb Biotechnologies and Revvity have announced the launch of a suite of new solutions and services that expand the frontiers of single-cell biology.
NGS
Whitepaper

Accelerate Your NGS Workflows

This whitepaper highlights how vendor-qualified, automated library preparation methods can accelerate a variety of NGS workflows.



The Signals Research Suite software.
Product News

Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development

Revvity, Inc announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.
Cell Immunophenotyping
App Note / Case Study

Novel High-Throughput Image Cytometry Method for T-Cell Immunophenotyping and Viability Readouts

The cell therapy manufacturing process requires the guidance of chemical manufacturing and controls for analytical method development focusing on the critical quality attributes (CQAs).
DNA biology
Infographic

The Great Story of Gene Therapy

Gene therapy aims to be a one-time treatment targeting a faulty gene that causes a disease and either replacing it with a functional gene or altering the gene expression.
Advertisement